Synpromics will be in San Francisco for JP Morgan and looking to meet with Cell and Gene Therapy companies and investors.
About the event
Thirty five years ago, we launched Wall Street's premier investor conference focused exclusively on companies defining the healthcare industry. Today, the J.P. Morgan Healthcare Conference continues our tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2018, we expect more than 400 companies, both public and private, to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting.
Please remember that all J.P. Morgan conferences are by invitation only. There are restrictions on attendance for this conference. Invitations are non-transferable.
Please get in touch with David Venables, CEO Synpromics, at firstname.lastname@example.org, to arrange meeting with him at the event.